Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Genomma Lab Internacional Dividend Announcement
• Genomma Lab Internacional announced a quarterly dividend of Mex$0.20 per ordinary share which will be made payable on . Ex dividend date: 2024-09-13
• Genomma Lab Internacional annual dividend for 2024 was Mex$0.79
• Genomma Lab Internacional annual dividend for 2023 was Mex$0.59
• Genomma Lab Internacional's trailing twelve-month (TTM) dividend yield is 4.37%
• Genomma Lab Internacional's payout ratio for the trailing twelve months (TTM) is 37.17%
Genomma Lab Internacional Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-13 | Mex$0.20 | quarterly | |
2024-06-20 | Mex$0.20 | quarterly | |
2024-03-22 | Mex$0.20 | quarterly | |
2024-03-21 | Mex$0.20 | quarterly | |
2023-12-22 | Mex$0.20 | quarterly | |
2023-09-28 | Mex$0.20 | quarterly | |
2023-06-05 | Mex$0.20 | quarterly | |
2022-11-09 | Mex$0.38 | quarterly | |
2022-06-06 | Mex$0.38 | quarterly | |
2021-12-08 | Mex$0.38 | quarterly | |
2021-12-01 | Mex$0.76 | quarterly |
Genomma Lab Internacional Dividend per year
Genomma Lab Internacional Dividend growth
Genomma Lab Internacional Dividend Yield
Genomma Lab Internacional current trailing twelve-month (TTM) dividend yield is 4.37%. Interested in purchasing Genomma Lab Internacional stock? Use our calculator to estimate your expected dividend yield:
Genomma Lab Internacional Financial Ratios
Genomma Lab Internacional Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Genomma Lab Internacional stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.